Biosimilar use in France

Like generic drugs for small molecules, biosimilars offer the hope for reducing drug prices after biologic therapies lose their patent protections. But how big an impact do biosimilars have and how comfortable are physicians with using these substitute products? A paper by Robinson and Jarrion (2021) use data from France as a case study to…

Demand curves still slope downwards

Unsurprisingly, high-deductible health plans lead to lower utilization of healthcare services. A study by Sandoval et al. (2021) use data from 2007-2019 from Switzerland to show that this is the case. Participants with high-deductible plans reported forgoing health care more frequently than those with low-deductible plans (331 [13.5%] vs 591 [8.7%]). In adjusted analysis, higher-deductible…

The 3Cs

The Economist has an interesting article on how Japan has been able to largely contain COVID-19. Part of the success has been a strong public health initiatives around avoiding the san-mitsu, or the “3Cs”. The 3Cs to avoid are: Closed spaces, Crowded places, and Close-contact settings. The phrase was blasted across traditional and social media.…